Muneer A Satter - Net Worth and Insider Trading

Muneer A Satter Net Worth

The estimated net worth of Muneer A Satter is at least $65 Million dollars as of 2025-04-29. Muneer A Satter is the 10% Owner of Heartware International Inc and owns about 714,286 shares of Heartware International Inc (HTWR) stock worth over $41 Million. Muneer A Satter is the Director, 10% Owner of Annexon Inc and owns about 7,406,024 shares of Annexon Inc (ANNX) stock worth over $14 Million. Muneer A Satter is also the Director of Akebia Therapeutics Inc and owns about 3,037,042 shares of Akebia Therapeutics Inc (AKBA) stock worth over $7 Million. Besides these, Muneer A Satter also holds Rein Therapeutics Inc (RNTX) , Aerpio Pharmaceuticals Inc (ARPO) , Immunic Inc (IMUX) . Details can be seen in Muneer A Satter's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Muneer A Satter has not made any transactions after 2023-12-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Muneer A Satter

Muneer A Satter Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Muneer A Satter owns 9 companies in total, including Annexon Inc (ANNX) , Rein Therapeutics Inc (RNTX) , and Aerpio Pharmaceuticals Inc (ARPO) among others .

Click here to see the complete history of Muneer A Satter’s form 4 insider trades.

Insider Ownership Summary of Muneer A Satter

Ticker	Company	Transaction Date	Type of Owner
ANNX	Annexon Inc	2023-12-26	director
RNTX	Rein Therapeutics Inc	2021-01-08	10 percent owner
ARPO	Aerpio Pharmaceuticals Inc	2019-06-18	director & 10 percent owner
		2018-09-17	director & 10 percent owner
		2017-07-05	director
		2014-09-16	10 percent owner
		2009-08-13	10 percent owner
		2017-03-15	director & 10 percent owner
		2021-08-12	director

Muneer A Satter Latest Holdings Summary

Muneer A Satter currently owns a total of 6 stocks. Among these stocks, Muneer A Satter owns 714,286 shares of Heartware International Inc (HTWR) as of August 13, 2009, with a value of $41 Million and a weighting of 63.32%. Muneer A Satter owns 7,406,024 shares of Annexon Inc (ANNX) as of December 26, 2023, with a value of $14 Million and a weighting of 21.46%. Muneer A Satter also owns 3,037,042 shares of Akebia Therapeutics Inc (AKBA) as of July 5, 2017, with a value of $7 Million and a weighting of 11.1%. The other 3 stocks Rein Therapeutics Inc (RNTX) , Aerpio Pharmaceuticals Inc (ARPO) , Immunic Inc (IMUX) have a combined weighting of 4.12% among all his current holdings.

Latest Holdings of Muneer A Satter

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HTWR	Heartware International Inc	2009-08-13	714,286	57.98	41,414,302
ANNX	Annexon Inc	2023-12-26	7,406,024	1.90	14,034,415
AKBA	Akebia Therapeutics Inc	2017-07-05	3,037,042	2.39	7,258,530
RNTX	Rein Therapeutics Inc	2021-01-08	830,472	1.76	1,462,627
ARPO	Aerpio Pharmaceuticals Inc	2019-01-10	374,791	2.20	824,540
IMUX	Immunic Inc	2018-09-17	363,426	1.13	410,671

Holding Weightings of Muneer A Satter

Muneer A Satter Form 4 Trading Tracker

According to the SEC Form 4 filings, Muneer A Satter has made a total of 0 transactions in Heartware International Inc (HTWR) over the past 5 years. The most-recent trade in Heartware International Inc is the acquisition of 3 shares on August 13, 2009, which cost Muneer A Satter around $71.

According to the SEC Form 4 filings, Muneer A Satter has made a total of 4 transactions in Annexon Inc (ANNX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Annexon Inc is the acquisition of 350,000 shares on December 26, 2023, which cost Muneer A Satter around $1 Million.

According to the SEC Form 4 filings, Muneer A Satter has made a total of 0 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years. The most-recent trade in Akebia Therapeutics Inc is the acquisition of 1,034,482 shares on July 5, 2017, which cost Muneer A Satter around $15 Million.

More details on Muneer A Satter's insider transactions can be found in the Insider Trading History of Muneer A Satter table.

Insider Trading History of Muneer A Satter

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Muneer A Satter Trading Performance

GuruFocus tracks the stock performance after each of Muneer A Satter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Muneer A Satter is 14.35%. GuruFocus also compares Muneer A Satter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Muneer A Satter within 3 months outperforms 18 times out of 28 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Muneer A Satter's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Muneer A Satter

Average Return

Average return per transaction

Outperforming Transactions

10 out of 29 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	24.49
Relative Return to S&P 500(%)	22.53

Muneer A Satter Ownership Network

Ownership Network List of Muneer A Satter

No Data

Ownership Network Relation of Muneer A Satter

Muneer A Satter Owned Company Details

What does Annexon Inc do?

Who are the key executives at Annexon Inc?

Muneer A Satter is the director of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Scientific Officer Dean Richard Artis , EVP & Chief Innovation Officer Ted Yednock , and EVP & Chief Business Officer Michael Overdorf .

Annexon Inc (ANNX) Insider Trades Summary

Over the past 18 months, Muneer A Satter made 1 insider transaction in Annexon Inc (ANNX) with a net purchase of 350,000. Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 85,113 shares made by Ted Yednock , a net purchase of 25,600 shares made by William H. Carson , and a net sale of 14,204 shares made by Jennifer Lew .

In summary, during the past 3 months, insiders sold 42,926 shares of Annexon Inc (ANNX) in total and bought 0 shares, with a net sale of 42,926 shares. During the past 18 months, 133,283 shares of Annexon Inc (ANNX) were sold and 375,600 shares were bought by its insiders, resulting in a net purchase of 242,317 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Annexon Inc Insider Transactions

No Available Data

What does Rein Therapeutics Inc do?

Who are the key executives at Rein Therapeutics Inc?

Muneer A Satter is the 10 percent owner of Rein Therapeutics Inc. Other key executives at Rein Therapeutics Inc include See Remarks James Brian Windsor , See Remarks Susan L. Drexler , and SVP & Chief Medical Officer Vojo Vukovic .

Rein Therapeutics Inc (RNTX) Insider Trades Summary

Over the past 18 months, Muneer A Satter made no insider transaction in Rein Therapeutics Inc (RNTX). Other recent insider transactions involving Rein Therapeutics Inc (RNTX) include a net sale of 95,059 shares made by , and a net purchase of 5,701 shares made by James Brian Windsor .

In summary, during the past 3 months, insiders sold 0 shares of Rein Therapeutics Inc (RNTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 95,059 shares of Rein Therapeutics Inc (RNTX) were sold and 5,701 shares were bought by its insiders, resulting in a net sale of 89,358 shares.

Rein Therapeutics Inc (RNTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rein Therapeutics Inc Insider Transactions

No Available Data

What does Aerpio Pharmaceuticals Inc do?

Who are the key executives at Aerpio Pharmaceuticals Inc?

Muneer A Satter is the director & 10 percent owner of Aerpio Pharmaceuticals Inc. Other key executives at Aerpio Pharmaceuticals Inc include director & 10 percent owner Orbimed Advisors Llc , Vice President of Finance Regina Marek , and director & President Joseph H. Gardner .

Aerpio Pharmaceuticals Inc (ARPO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerpio Pharmaceuticals Inc (ARPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerpio Pharmaceuticals Inc (ARPO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerpio Pharmaceuticals Inc (ARPO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerpio Pharmaceuticals Inc Insider Transactions

No Available Data

What does Immunic Inc do?

Who are the key executives at Immunic Inc?

Muneer A Satter is the director & 10 percent owner of Immunic Inc. Other key executives at Immunic Inc include director & CEO & President Daniel Vitt , PAO and Controller Glenn Whaley , and Chief Medical Officer Andreas Muehler .

Immunic Inc (IMUX) Insider Trades Summary

Over the past 18 months, Muneer A Satter made no insider transaction in Immunic Inc (IMUX). Other recent insider transactions involving Immunic Inc (IMUX) include a net purchase of 87,300 shares made by Richard Alan Rudick , and a net purchase of 14,000 shares made by Daniel Vitt .

In summary, during the past 3 months, insiders sold 0 shares of Immunic Inc (IMUX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunic Inc (IMUX) were sold and 101,300 shares were bought by its insiders, resulting in a net purchase of 101,300 shares.

Immunic Inc (IMUX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immunic Inc Insider Transactions

No Available Data

What does Akebia Therapeutics Inc do?

Who are the key executives at Akebia Therapeutics Inc?

Muneer A Satter is the director of Akebia Therapeutics Inc. Other key executives at Akebia Therapeutics Inc include SVP & Chief Medical Officer Steven Keith Burke , director & CEO & President John P. Butler , and SVP & Chief Business Officer Michel Dahan .

Akebia Therapeutics Inc (AKBA) Insider Trades Summary

Over the past 18 months, Muneer A Satter made no insider transaction in Akebia Therapeutics Inc (AKBA). Other recent insider transactions involving Akebia Therapeutics Inc (AKBA) include a net sale of 73,186 shares made by Steven Keith Burke , a net sale of 228,553 shares made by John P. Butler , and a net sale of 54,245 shares made by Michel Dahan .

In summary, during the past 3 months, insiders sold 287,723 shares of Akebia Therapeutics Inc (AKBA) in total and bought 0 shares, with a net sale of 287,723 shares. During the past 18 months, 467,208 shares of Akebia Therapeutics Inc (AKBA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 467,208 shares.

Akebia Therapeutics Inc (AKBA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akebia Therapeutics Inc Insider Transactions

No Available Data

What does Eledon Pharmaceuticals Inc do?

Who are the key executives at Eledon Pharmaceuticals Inc?

Muneer A Satter is the 10 percent owner of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & See Remarks Steven Perrin , and director & Chief Executive Officer David-alexandre C Gros .

Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eledon Pharmaceuticals Inc Insider Transactions

No Available Data

What does Heartware International Inc do?

Who are the key executives at Heartware International Inc?

Muneer A Satter is the 10 percent owner of Heartware International Inc. Other key executives at Heartware International Inc include director & President & Chief Exec Officer Douglas Evan Godshall , 10 percent owner Adage Capital Partners Gp, L.l.c. , and 10 percent owner Adage Capital Partners, L.p. .

Heartware International Inc (HTWR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Heartware International Inc (HTWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heartware International Inc (HTWR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Heartware International Inc (HTWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Heartware International Inc Insider Transactions

No Available Data

What does Whitehawk Therapeutics Inc do?

Who are the key executives at Whitehawk Therapeutics Inc?

Muneer A Satter is the director & 10 percent owner of Whitehawk Therapeutics Inc. Other key executives at Whitehawk Therapeutics Inc include director & Chief Executive Officer David James Lennon , Chief Financial Officer Scott M. Giacobello , and director & See Remarks Neil Desai .

Whitehawk Therapeutics Inc (WHWK) Insider Trades Summary

Over the past 18 months, Muneer A Satter made no insider transaction in Whitehawk Therapeutics Inc (WHWK). Other recent insider transactions involving Whitehawk Therapeutics Inc (WHWK) include a net sale of 450,000 shares made by Neil Desai , a net sale of 15,379 shares made by David James Lennon , and a net sale of 2,806 shares made by Scott M. Giacobello .

In summary, during the past 3 months, insiders sold 10,643 shares of Whitehawk Therapeutics Inc (WHWK) in total and bought 0 shares, with a net sale of 10,643 shares. During the past 18 months, 470,332 shares of Whitehawk Therapeutics Inc (WHWK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 470,332 shares.

Whitehawk Therapeutics Inc (WHWK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Whitehawk Therapeutics Inc Insider Transactions

No Available Data

What does AxonPrime Infrastructure Acquisition Corp do?

Who are the key executives at AxonPrime Infrastructure Acquisition Corp?

Muneer A Satter is the director of AxonPrime Infrastructure Acquisition Corp. Other key executives at AxonPrime Infrastructure Acquisition Corp include 10 percent owner Axon Partners, Lp , 10 percent owner Axon Capital Lp , and 10 percent owner Dakin Sloss .

AxonPrime Infrastructure Acquisition Corp (APMI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AxonPrime Infrastructure Acquisition Corp (APMI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AxonPrime Infrastructure Acquisition Corp (APMI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AxonPrime Infrastructure Acquisition Corp (APMI)'s detailed insider trading history can be found in Insider Trading Tracker table.

AxonPrime Infrastructure Acquisition Corp Insider Transactions

No Available Data

Muneer A Satter Mailing Address

Above is the net worth, insider trading, and ownership report for Muneer A Satter. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Muneer A Satter's mailing address is: Chicago Il 60611.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.